Minimization of Treatment Time Using Partial-Arc Volumetric Modulated Arc Therapy with Bladder Filling Protocol for Prostate Cancer |
Hojeong Lee
(Department of Radiation Oncology and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital)
Dong Woon Kim (Department of Radiation Oncology and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital) Ji Hyeon Joo (Department of Radiation Oncology and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital) Yongkan Ki (Department of Radiation Oncology and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital) Wontaek Kim (Department of Radiation Oncology, Pusan National University School of Medicine) Dahl Park (Department of Radiation Oncology, Pusan National University Hospital) Jiho Nam (Department of Radiation Oncology, Pusan National University Hospital) Dong Hyeon Kim (Department of Radiation Oncology, Pusan National University School of Medicine) Hosang Jeon (Department of Radiation Oncology and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital) |
1 | Zaorsky NG, Palmer JD, Hurwitz MD, Keith SW, Dicker AP, Den RB. What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalation. Radiother Oncol. 2015;115:295-300. DOI |
2 | Dearnaley D, Syndikus I, Mossop H, Khoo V, Birtle A, Bloomfield D, et al. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Lancet Oncol. 2016;17:1047-1060. Erratum in: Lancet Oncol. 2016;17:e321. DOI |
3 | Fischer-Valuck BW, Rao YJ, Michalski JM. Intensity-modulated radiotherapy for prostate cancer. Transl Androl Urol. 2018;7:297-307. DOI |
4 | Hoffmann M, Pacey J, Goodworth J, Laszcyzk A, Ford R, Chick B, et al. Analysis of a volumetric-modulated arc therapy (VMAT) single phase prostate template as a class solution. Rep Pract Oncol Radiother. 2019;24:92-96. DOI |
5 | Stam MR, van Lin EN, van der Vight LP, Kaanders JH, Visser AG. Bladder filling variation during radiation treatment of prostate cancer: can the use of a bladder ultrasound scanner and biofeedback optimize bladder filling? Int J Radiat Oncol Biol Phys. 2006;65:371-377. DOI |
6 | Yoon HI, Chung Y, Chang JS, Lee JY, Park SJ, Koom WS. Evaluating variations of bladder volume using an ultrasound scanner in rectal cancer patients during chemoradiation: is protocol-based full bladder maintenance using a bladder scanner useful to maintain the bladder volume? PLoS One. 2015;10:e0128791. |
7 | Smith GA, Dunlop A, Barnes H, Herbert T, Lawes R, Mohajer J, et al. Bladder filling in patients undergoing prostate radiotherapy on a MR-linac: the dosimetric impact. Tech Innov Patient Support Radiat Oncol. 2022;21:41-45. DOI |
8 | O'Doherty UM, McNair HA, Norman AR, Miles E, Hooper S, Davies M, et al. Variability of bladder filling in patients receiving radical radiotherapy to the prostate. Radiother Oncol. 2006;79:335-340. |
9 | Braide K, Kindblom J, Lindencrona U, Mansson M, Hugosson J. The value of a bladder-filling protocol for patients with prostate cancer who receive post-operative radiation: results from a prospective clinical trial. Acta Oncol. 2019;58:463-468. DOI |
10 | Michalski JM, Gay H, Jackson A, Tucker SL, Deasy JO. Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S123-S129. Erratum in: Int J Radiat Oncol Biol Phys. 2019;104:1185. DOI |